Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 700 shares, a drop of 95.3% from the September 30th total of 15,000 shares. Based on an average daily volume of 215,500 shares, the short-interest ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group started coverage on shares of Merck KGaA in a report on Thursday, September 19th. They set a “buy” rating on the stock.
Get Our Latest Analysis on MKKGY
Merck KGaA Trading Down 0.2 %
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- Want to Profit on the Downtrend? Downtrends, Explained.
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Insider Trading – What You Need to Know
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Using the MarketBeat Dividend Tax Calculator
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.